Giulia Benevolo

29PUBLICATIONS

124CO-AUTHORS

Predictive and prognostic markersMedical mycologyAutoimmunityHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (29)

Sort by Publication Date:

|Jun 11, 2026

A dynamic prognostic model for Polycythemia Vera long-terms outcomes in patients treated with Ruxolitinib.

|May 12, 2026

Clinical benefit and predictors of response to momelotinib after ruxolitinib failure: A cooperative real-world study.

|Mar 19, 2026

Quantitative MYD88 L265P and flow cytometry levels for outcome determination in IgM gammopathies: the SAL-TO study.

Irene Dogliotti, Cristina Jiménez, Veronica Peri

|Mar 05, 2026

Genomic profiling for decision-making in post-polycythemia vera and post-essential thrombocythemia myelofibrosis.

Barbara Mora, Francesca Palandri, Paola Guglielmelli

|Feb 13, 2026

Survival and quality-of-life implications of cytopenia trajectories in ruxolitinib-treated myelofibrosis.

Francesca Palandri, Giovanni Caocci, Elisabetta Abruzzese

|Feb 12, 2026

Ibrutinib or non-BTK inhibitor therapy in relapsed Waldenström macroglobulinemia: a real-life multicenter Italian study.

Francesco Autore, Alessandra Tedeschi, Giulia Benevolo

Pageof 5

Frequent Collaborators

15 joint publications

Francesca Palandri

14 joint publications

Massimo Breccia

13 joint publications

Mario Tiribelli

12 joint publications

Alessandra Iurlo

11 joint publications

Elisabetta Abruzzese

11 joint publications

Novella Pugliese

10 joint publications

Massimiliano Bonifacio

9 joint publications

Elena Rossi

6 joint publications

Valerio De Stefano

4 joint publications

Tiziano Barbui